DK153947C - Analogifremgangsmaade til fremstilling af halogensubstituerede benzopyran- eller benzothiopyran-4-carboxylsyre-forbindelser eller c1-4alkylestere deraf eller farmaceutisk acceptable salte deraf med baser - Google Patents
Analogifremgangsmaade til fremstilling af halogensubstituerede benzopyran- eller benzothiopyran-4-carboxylsyre-forbindelser eller c1-4alkylestere deraf eller farmaceutisk acceptable salte deraf med baserInfo
- Publication number
- DK153947C DK153947C DK471079A DK471079A DK153947C DK 153947 C DK153947 C DK 153947C DK 471079 A DK471079 A DK 471079A DK 471079 A DK471079 A DK 471079A DK 153947 C DK153947 C DK 153947C
- Authority
- DK
- Denmark
- Prior art keywords
- benzothiopyrane
- saltable
- benzopyrane
- alkylesters
- analogue
- Prior art date
Links
- ZNVUAOZSTLMGQO-UHFFFAOYSA-N 2h-thiochromene-4-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=CCSC2=C1 ZNVUAOZSTLMGQO-UHFFFAOYSA-N 0.000 title 1
- 150000001562 benzopyrans Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/959,023 US4210663A (en) | 1978-11-08 | 1978-11-08 | Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids |
US95902378 | 1978-11-08 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK471079A DK471079A (da) | 1980-05-09 |
DK153947B DK153947B (da) | 1988-09-26 |
DK153947C true DK153947C (da) | 1989-02-20 |
Family
ID=25501572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK471079A DK153947C (da) | 1978-11-08 | 1979-11-07 | Analogifremgangsmaade til fremstilling af halogensubstituerede benzopyran- eller benzothiopyran-4-carboxylsyre-forbindelser eller c1-4alkylestere deraf eller farmaceutisk acceptable salte deraf med baser |
Country Status (16)
Country | Link |
---|---|
US (1) | US4210663A (ko) |
EP (1) | EP0011426B1 (ko) |
JP (2) | JPS6033433B2 (ko) |
KR (1) | KR830001821B1 (ko) |
AR (1) | AR223195A1 (ko) |
AT (1) | AT366680B (ko) |
AU (1) | AU513399B2 (ko) |
CA (1) | CA1132584A (ko) |
DE (1) | DE2965755D1 (ko) |
DK (1) | DK153947C (ko) |
ES (1) | ES485798A1 (ko) |
FI (1) | FI71139C (ko) |
IE (1) | IE49109B1 (ko) |
IL (1) | IL58656A (ko) |
PT (1) | PT70420A (ko) |
YU (1) | YU41675B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4305955A (en) * | 1980-10-21 | 1981-12-15 | Pfizer Inc. | Carboxylic acid therapeutic agents |
US4486428A (en) * | 1982-03-16 | 1984-12-04 | Pfizer Inc. | Bicyclic benzo fused compounds |
US4537920A (en) * | 1983-08-18 | 1985-08-27 | Ethyl Corporation | 4H-1-benzopyrans and lubricant compositions containing same |
US4551542A (en) * | 1984-09-26 | 1985-11-05 | Pfizer Inc. | Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid |
HU206618B (en) * | 1986-01-17 | 1992-12-28 | Pfizer | Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them |
DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
US5039672A (en) * | 1990-04-05 | 1991-08-13 | Pfizer Inc. | Heterocyclic compounds as aldose reductase inhibitors |
ES2111572T3 (es) * | 1990-07-27 | 1998-03-16 | Chugai Pharmaceutical Co Ltd | Nuevo derivado de benzopirano. |
JP3255411B2 (ja) * | 1991-02-18 | 2002-02-12 | 中外製薬株式会社 | 発毛促進剤 |
US5407897A (en) * | 1993-03-03 | 1995-04-18 | American Cyanamid Company | Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds |
AU2440599A (en) * | 1998-02-25 | 1999-09-15 | Shionogi & Co., Ltd. | Therapeutic agent for complication of diabetes |
US7288279B2 (en) * | 2001-12-21 | 2007-10-30 | Michael Foods Of Delaware, Inc. | Formulated fried egg product |
JP4742215B2 (ja) * | 2003-06-23 | 2011-08-10 | Jnc株式会社 | クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子 |
JP5956920B2 (ja) | 2012-12-14 | 2016-07-27 | 株式会社コガネイ | 液体供給装置 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
-
1978
- 1978-11-08 US US05/959,023 patent/US4210663A/en not_active Expired - Lifetime
-
1979
- 1979-11-05 YU YU2697/79A patent/YU41675B/xx unknown
- 1979-11-06 DE DE7979302467T patent/DE2965755D1/de not_active Expired
- 1979-11-06 EP EP79302467A patent/EP0011426B1/en not_active Expired
- 1979-11-06 CA CA339,283A patent/CA1132584A/en not_active Expired
- 1979-11-06 AR AR278784A patent/AR223195A1/es active
- 1979-11-07 JP JP54144280A patent/JPS6033433B2/ja not_active Expired
- 1979-11-07 ES ES485798A patent/ES485798A1/es not_active Expired
- 1979-11-07 PT PT70420A patent/PT70420A/pt unknown
- 1979-11-07 AU AU52582/79A patent/AU513399B2/en not_active Ceased
- 1979-11-07 FI FI793487A patent/FI71139C/fi not_active IP Right Cessation
- 1979-11-07 KR KR1019790003889A patent/KR830001821B1/ko active IP Right Grant
- 1979-11-07 IL IL58656A patent/IL58656A/xx unknown
- 1979-11-07 DK DK471079A patent/DK153947C/da not_active IP Right Cessation
- 1979-11-07 IE IE2136/79A patent/IE49109B1/en unknown
- 1979-11-08 AT AT0719279A patent/AT366680B/de not_active IP Right Cessation
-
1980
- 1980-12-15 JP JP17706780A patent/JPS56103176A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
ATA719279A (de) | 1981-09-15 |
IL58656A0 (en) | 1980-02-29 |
FI71139C (fi) | 1986-11-24 |
EP0011426B1 (en) | 1983-06-22 |
JPS56103176A (en) | 1981-08-18 |
AR223195A1 (es) | 1981-07-31 |
DK153947B (da) | 1988-09-26 |
IE792136L (en) | 1980-05-08 |
KR830001821B1 (ko) | 1983-09-12 |
AU513399B2 (en) | 1980-11-27 |
IL58656A (en) | 1983-06-15 |
EP0011426A1 (en) | 1980-05-28 |
JPS6113716B2 (ko) | 1986-04-15 |
YU41675B (en) | 1987-12-31 |
DK471079A (da) | 1980-05-09 |
AU5258279A (en) | 1980-05-15 |
CA1132584A (en) | 1982-09-28 |
YU269779A (en) | 1983-02-28 |
ES485798A1 (es) | 1980-10-01 |
PT70420A (de) | 1979-12-01 |
FI793487A (fi) | 1980-05-09 |
JPS6033433B2 (ja) | 1985-08-02 |
KR830001273A (ko) | 1983-04-30 |
JPS5585582A (en) | 1980-06-27 |
FI71139B (fi) | 1986-08-14 |
IE49109B1 (en) | 1985-08-07 |
AT366680B (de) | 1982-04-26 |
US4210663A (en) | 1980-07-01 |
DE2965755D1 (en) | 1983-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
DK164545C (da) | Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf | |
DK147362C (da) | Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf | |
DK153947C (da) | Analogifremgangsmaade til fremstilling af halogensubstituerede benzopyran- eller benzothiopyran-4-carboxylsyre-forbindelser eller c1-4alkylestere deraf eller farmaceutisk acceptable salte deraf med baser | |
DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
DK148537C (da) | Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf | |
DK157862C (da) | Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
DK149569C (da) | Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf | |
DK162166C (da) | Analogifremgangsmaade til fremstilling af (2s)-isomere af 2-oe4-(2-hydroxycyclopentan-1-ylmethyl)phenylaapropionsyre eller farmaceutisk acceptable salte deraf | |
DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
DK154950C (da) | Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf | |
DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
DK158983C (da) | Analogifremgangsmaade til fremstilling af benzoylpiperazinestre eller syreadditionssalte deraf | |
DK164551C (da) | Analogifremgangsmaade til fremstilling af cyclohexylthienyleddikesyreamider eller fysiologisk taalelige syreadditionssalte deraf | |
DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
DK160498C (da) | Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf | |
DK165005C (da) | Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf | |
DK162102C (da) | Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf | |
DK152427C (da) | Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
DK152491C (da) | Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf | |
DK157023C (da) | Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
DK148019C (da) | Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf | |
DK148903C (da) | Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |